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Migration and invasionThere have been many reports of mitochondrial DNA (mtDNA) mutations associated with human malignan-
cies. We have observed allelic instability in UV-induced cutaneous tumors at themt-Tr locus encoding the mi-
tochondrial tRNA for arginine. We examined the effects of somatic alterations at this locus by modeling the
change in a uniform nuclear background by generating cybrids harboring allelic variation at mt-Tr. We uti-
lized the naturally occurring mtDNA variation at mt-Tr within the BALB/cJ (BALB) and C57BL/6J (B6) strains
ofMus musculus to transfer their mitochondria into a mouse ρ0 cell line that lacked its own mtDNA. The BALB
haplotype containing themt-Tr 9821insA allele produced signiﬁcant changes in cellular respiration (resulting
in lowered ATP production), but increased rates of cellular proliferation in cybrid cells. Furthermore, the
mtDNA genotype associated with UV-induced tumors endowed the cybrid cells with a phenotype of resis-
tance to UV-induced apoptosis and enhanced migration and invasion capabilities. These studies support a
role for mtDNA changes in cancer.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Although mtDNA mutations have been observed frequently in
human malignancies [1,2] their functional signiﬁcance is not fully
understood. One limitation of the approach of studying mtDNA
mutations in humans is that there is abundant mtDNA sequence
heterogeneity in the form of inherited polymorphisms. Although
this naturally occurring variation is helpful for the study of maternal
ancestry [3], it confounds studies to examine the effects of speciﬁc
mutations given that they arise in a background that is inherently
heterogeneous.
We previously observed somatic alterations in the mitochondrial
tRNAArg gene in UV induced mouse skin tumors and modeled the
effects of somatic variation at mt-Tr by harvesting mitochondriaraviolet; ROS, Reactive Oxida-
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rights reserved.from brain synaptosomes of B6 and BALB mice and transferring
them to a mouse ﬁbroblast ρ0 cell line (LMEB3ρ0) that lacked its
own mtDNA [4]. The resulting cybrid cell lines LMEB3 (mtBALB) and
LMEB3( mtB6) contain the same nuclear genotype and differ in
their mitochondria at three nucleotides. The locations of the mtDNA
differences between B6 (the mouse reference sequence) and
BALB are a T to C polymorphism at 9461 and a 9348G to A change
resulting in the amino acid change V248I which is thought to be a
neutral polymorphism [5,6]. The ﬁnal difference between the two
strains is an additional A insertion in the mt-Tr locus resulting in
the expansion of a homopolymeric A tract in the pseudouridine loop
of the tRNAArg molecule (from 8 consecutive A residues (the B6 refe-
rence sequence) to 9 consecutive As (9821insA)). Alterations of this
molecule potentially affect the synthesis of all mitochondrially-
encoded proteins that contain arginine. An acquired somatic alter-
ation at the locus would produce heteroplasmy of both B6 and BALB
mitochondrial tRNAArg alleles. Inherited mtDNA changes at mt-Tr
are associated with sensorineural hearing loss [7], and modulation
of complex phenotypes such as learning [8].
We analyzed the effects of this nucleotide insertion in the mtDNA
by studying cybrids that harbor alterations at this locus. Our results
show that the mtBALB haplotype cybrid cells harboring 9821insA
[LMEB3(mtBALB)] has readily observable increased rates of cellular
proliferation that were associated with alterations in respiratory
activity. This haplotype was also associated with diminished levels
of complex I protein resulting in lower levels of baseline oxygen con-
sumption and lower cellular ATP levels [4]. The mtBALB haplotype
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(ROS) and striking changes in cellular motility such as increased mi-
gration through transwell pore openings and increased invasion
through matrigel matrix. Finally, the cybrids that contain the BALB
mtDNA haplotype also were endowed with a resistance to UV-
induced apoptosis compared to the B6 haplotype. These altered bio-
chemical and behavioral changes produced by the mtBALB haplotype
containing the mt-Tr 9821insA allele result in phenotypes that are
consistent with those of tumor cells.2. Materials and methods
2.1. Cell lines and media
All cell lines were grown in high glucose (4.5 g/L) DMEMmedium
(Invitrogen Corporation, Carlsbad, CA) supplemented with 10% FBS
(Invitrogen Corporation, Carlsbad, CA). Where indicated, cells were
grown in DMEM lacking glucose but containing 4.5 g/L of galactose
supplemented with 10% FBS. LMEB3(mtBALB) and LMEB3(mtB6)
cells were generated by harvesting the mitochondria from brain syn-
aptosomes of B6 and BALB mice and electrofusing them to a mouse ﬁ-
broblast LMEB3ρ0 cell line that lacked its own mtDNA [4]. We
produced two cybrid cell lines which differ only in their mtDNA but
have identical nuclear background from murine LA9 cells which are
of C3H origin. The genetics of LA9 cells is discussed in the study of
Bayona-Bafaluy et al. [6]. A mouse LMEB3ρ0 cell line was produced
by exposure of LM(TK−) cells to ethidium bromide as described pre-
viously by Trounce et al. [9]. Clonal isolates were obtained by picking
single colonies after fusion and growing them through successive
passaging for over a month prior to beginning experiments. The con-
tinued propagation of the cells in culture eliminates any potential
contribution of small molecules in the mitochondria of the donor
cell line. All cellular compartments would be expected to consist of
only molecules synthesized from the LMEB3 nuclear DNA and the do-
nated mtDNA.2.2. Proliferation assay
Both mtB6 and mtBALB cybrid cells were plated in the 6-well
plates at concentration 1×105 per well. Cells were incubated in either
high glucose DMEM with or without 10 μg/ml Mito C (Sigma Aldrich,
St. Louis, MO) or in DMEM supplemented with 4.5 g/L galactose.
Cybrid cells were also grown in high glucose DMEM supplemented
with antioxidants such as 200 μM vit E (Sigma Aldrich, St. Louis,
MO) and 10 mM NAC (Sigma Aldrich, St. Louis, MO) for 24 h, 48 h
and 72 h, respectively.
Where indicated, cells were pre-incubated for 7 d in the presence
of 10 mM NAC and then plated to test their ability to grow in DMEM
containing glucose or galactose plus NAC. Viable cells were counted
with a hemocytometer every other day by the trypan blue exclusion
method.Fig. 1.Mitochondrial DNA/nuclear DNA ratio is not signiﬁcantly different in mtBALB or
mtB6 cybrid cells. Mitochondrial DNA to nuclear DNA copy number was measured by
quantitative real time PCR. Values represent the mean±SEM of three independent ex-
periments of ﬁve clones.2.3. ROS levels measurement
ROS production was detected by using the ﬂuorescent probe
DCFH2-DA (Molecular Probes, Carlsbad, CA). Cybrid cells were seeded
in 96-well plates (5×104/well) and allowed to attach for 4 h, cells
were washed with Hanks' Balanced Salt Solution (Invitrogen
Corporation, Carlsbad, CA) and preloaded with 10 μM DCFH2-DA at
37 °C for 60 min. Next, the loading buffer was removed and the cells
were returned to prewarmed DMEM without phenol red, ﬂuorescence
measurements (excitation and emission wavelengths of 490 and
525 nm, respectively) were carried out with a Synergy HT ﬂuorimetric
plate reader (Biotek, Winooski, VT).2.4. UVA radiation induced apoptosis
Cybrid cells at concentration 2×105 cells/well growing in 6-well
plate (50–60% conﬂuent) were irradiated with 15 J UVA from our
panel (Solarc Systems Inc., Minesing (Barrie), Ontario, Canada) of ul-
traviolet bulbs (six F72T12-BL-HO UVA) that deliver broadband UVA
with peak output between 340 and 368 nm. The UVA dose was mon-
itored with a UVA meter (National Biological Corporation, Beach-
wood, OH) [10]. Treated cells were harvested and stained with
Annexin V and 7-AAD included in the Annexin V-PE apoptosis detec-
tion kit I (BD Pharmingen, San Diego, CA), according to manufac-
turer's protocol. Flow cytometry analysis was performed on
FACScan ﬂow cytometer (Becton–Dickinson, Franklin Lakes, NJ)
equipped with a 488 nm argon laser with appropriate ﬁlters and
data were collected from gated cells of appropriate size. Obtained
results were analyzed using Cellquest software (Becton–Dickinson,
Franklin Lakes, NJ).
2.5. Transwell migration and invasion assay
Eight micrometer pore size translucent transwell migration cham-
bers (BD Biosciences, Bedford, MA) in 24-well plate were used for mi-
gration analysis. Brieﬂy, 600ul of Invasion buffer (DMEM containing
0.5% FBS and 0.1% BSA) was added to the bottom of each well, and a
total of 2.5×104 mtB6 or mtBALB cybrid cells resuspended in 150 μl
of Invasion buffer with or without 10 μg/ml Mito C or in the presence
of antioxidants such as vit E (200 μM) or NAC (10 mM) were seeded
on the top of the membrane. After 18 h incubation at 37 °C, 5% CO2,
non-invading cells were removed by wiping the upper side of the
membrane, and invading cells were ﬁxed with methanol and stained
with crystal violet (Sigma Aldrich, St. Louis, MO) for 1 min. The num-
ber of invading cells was quantiﬁed by counting 10 random ﬁelds per
ﬁlter at 400× magniﬁcation. Three membrane ﬁlters were used for
each condition within one experiment.
Cell invasion was performed using modiﬁed Boyden chambers
consisting of transwells with pre-coated Matrigel™membrane ﬁlters
inserted in 24-well tissue culture plates (BD Biosciences, Bedford,
MA). A total of 2.5×104 cybrid cells (75% conﬂuence) were resus-
pended in 300 μl of serum free media containing only 0.1% BSA and
placed on the top of each chamber. After 24 h incubation, invading
cybrid cells were stained with crystal violet and then quantiﬁed as
described above.
2.6. Mitochondrial DNA/nuclear DNA copy number ratio
Total DNA was extracted frommtB6 andmtBALB cybrid cells using
DNeasy Tissue DNA Isolation kit (Qiagen, Valencia, CA) according to
the manufacturer's instructions. mtDNA copy numbers/cell were
determined using the iQ SYBR Green Supermix (Bio-Rad, Hercules,
Fig. 2.mtBALB cybrid cells have higher proliferative rate than mtB6. (A) 1×105 cybrid cells were incubated in high glucose Dulbecco's modiﬁed Eagle's medium (DMEM) media for
the times indicated and viable cells shown. (B) To mitotically inactivate the cells, they were incubated in high glucose DMEM media in the presence of 10 μg/ml Mito C. (C) Cybrid
cells incubated in either high glucose DMEM or DMEM supplemented with 4.5 g/L galactose. Data are mean±SEM of three independent experiments of three clones. Asterisks in-
dicate statistical differences between the cybrid cells (*P valueb .05, **P valueb .005).
Fig. 3. ROS levels are higher in mtBALB cybrid cells. (A) ROS levels at rest or (B) in the
presence of 2 μM hydrogen peroxide. Data are mean±SEM of three independent
experiments of ﬁve clones. Asterisks indicate statistical difference between mtB6 and
mtBALB cybrid cells (*P valueb .05; **P valueb .005).
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mtDNA and nuclear DNA (nDNA) simultaneously. Primers were
designed and these sequences were used: COI.F: 5′-GCCTTTCAGGAA-
TACCACGA-3′, COI.R: 5′-AGGTTGGTTCCTCGAATGTG-3′; CIpB.F: 5′-
CACCGAGATCCCATACCTGA-3′, CIpB.R: 5′-GCTGTAGCACTGAAC-
CACCA-3′. The mitochondrial target spanned the genes for COX I,
and the nuclear target was the mouse CIpB caseinolytic peptidase B
homolog (E. coli). The PCR was performed in a total volume of 25 μL
containing DNA extracted from cybrids, 400 nm of each primer. Fol-
lowing thermal proﬁle was used: initial denaturation step for 5 min
at 95 °C, followed by 40 cycles of 95 °C for 10 s, 65 °C 30 s and 72 °C
30 s. The ampliﬁcation and detection were performed in an iCycler
real-time PCR detection system (Bio-Rad, Hercules, CA). Standard
curves from 10-fold serial dilutions of plasmid-cloned mitochondrion
COX I and nuclear CIpB DNA with known concentrations were gener-
ated to estimate the mtDNA and nDNA copy numbers in each sample.
Three parallels of ﬁve different concentrations of the standards were
used in each run throughout the study and each sample was analyzed
in triplicate. The exact mtDNA copy number per cell was obtained by
multiplying the mtDNA/nDNA ratio by two, as there are two nDNA
copies present in each cell.
2.7. Statistical analysis
Data were represented as mean±SEM of ﬁve clones. All experi-
ments were performed at least three times. Statistical signiﬁcance
between any two groups was determined by the two-tailed Student's
t-test, P values less than 0.05 were considered to be signiﬁcant.
3. Results
3.1. Mitochondrial DNA/nuclear DNA ratio are not signiﬁcantly different
in mtBALB or mtB6 cybrid cells
We characterized both LMEB3(mtBALB) and LMEB3(mtB6) cells
for nuclear/mitochondrial DNA ratio (Fig. 1) and we observed nosigniﬁcant differences between multiple clones of these two cybrid
lines. We selected a set of cybrid cell clones for further study that con-
tained similar mtDNA copy numbers, insuring that the cell lines
should not behave differently based on the mtDNA copy number.
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We observed a striking change in cellular proliferative activity be-
tween mtB6 and mtBALB cybrid cells. The media containing the
mtBALB cells showed a quicker color change indicating a higher rate
of acidity production than was seen in the mtB6 cells where the
media remained at a more constant pH over a greater time. As indi-
cated by Fig. 2A, there was a similar growth rate between both cybrid
lines after 24 h incubation in high glucose media but after 48 h and
72 h incubation, there was signiﬁcantly enhanced proliferative activ-
ity of mtBALB cells compared to mtB6. Fig. 2B indicates that Mitomy-
cin C is sufﬁcient to mitotically inactivate the cybrids what has to be
considered in further migratory experiments where the phenotype
of enhanced proliferation in mtBALB cybrids should be avoided. Addi-
tionally, we explored the proliferative behavior using galactose-
containing medium as an alternative sugar source to glucose. Overall,
the proliferation for each of the cybrid types was reduced in galactose
medium compared to glucose, although this effect was more pro-
found in the mtBALB cybrids. At 48 h and 72 h after plating, the
mtBALB cybrids had signiﬁcantly increased proliferation over the
mtB6 cybrids when grown in galactose, a result that mirrors what is
seen in glucose medium (Fig. 2C).Fig. 4. Proliferation rate of mtBALB cybrids is signiﬁcantly decreased by antioxidants in co
and treated with 200 μM vit E or 10 mM NAC after the cells were seeded. (B) cybrid cells w
well plates and incubated in high glucose DMEMor (C) DMEM supplementedwith 4.5 g/L gal
Viable cells are shown. Data are mean±SEM of three independent experiments of three c
**P valueb .005).3.3. ROS levels are higher in mtBALB cybrid cells
One theory that may explain the increased proliferative activity of
the mtBALB cybrid cells compared to the mtB6 cells would be an
increased level of ROS. While high levels of ROS are known to be
toxic to cells, low levels of ROS have been proposed as possible
mitogenic signals for cell growth [11–17]. We measured baseline
and hydrogen peroxide-stimulated ROS levels using ﬂuorescent 2′,
7-dichlorodihydroﬂuorescein diacetate (DCFH2-DA) analysis. The
results revealed signiﬁcantly higher levels of ROS at the baseline
(Fig. 3A) in the mtBALB cells compared to mtB6 cybrids indicating a
higher level of baseline oxidative stress. When the cells were stimu-
lated with H2O2, there was a profound increase in ROS levels in
cybrids of both genotypes, with a signiﬁcantly higher level observed
in the mtBALB cells compared to the mtB6 cybrids (Fig. 3B).
3.4. Proliferation rate of mtBALB cybrids is signiﬁcantly decreased by
antioxidants in comparison with mtB6 cybrids
We treated the cybrid cells with the antioxidant compounds N-
acetyl-L-cysteine (NAC) or vitamin E (vit E) to determine if scaveng-
ing ROS would diminish the proliferative capabilities of mtBALBmparison with mtB6. (A) 1.5×105 cybrid cells were incubated in high glucose DMEM
ere grown for 7 d in the presence of 10 mM NAC (Sigma) and then were plated in 6-
actose and additionally treated with 10 mMNAC for the 24 h, 48 h and 72 h as indicated.
lones. Asterisks indicate statistical differences between the cybrid cells (*P valueb .05,
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reduced the proliferative capacity of the mtBALB cybrids while having
no signiﬁcant antiproliferative effect on the mtB6 cybrids. Vit E
caused a greater reduction in proliferation of the cybrids than did
NAC, and the effect was not selective as was seen with NAC as the re-
duction in proliferation was signiﬁcant for both mtBALB and mtB6
cybrids compared to their untreated controls (Fig. 4A). Additionally,
we explored whether a 7 d pre-treatment with NAC in medium sup-
plemented with either glucose or galactose (conditions used in
Moreno-Loshuertos), would have the same or even more profound
effect on growing ability of cybrid cells [5]. We observed that NAC
did selectively slow down the growth of the mtBALB cybrids but
had no signiﬁcant antiproliferative effect on the mtB6 cybrids when
growing in glucose (Fig. 4B). The same effect was seen when cybrid
cells were growing in galactose medium (Fig. 4C). The ability of
NAC to selectively inhibit the proliferation of mtBALB over mtB6
cybrids (an effect not seen by vit E) may reﬂect the differences in ox-
ygen scavenging activity of the two compounds for speciﬁc radicals.3.5. mtBALB cybrids resist UVA-induced apoptosis compared to mtB6
cybrids
As the mt-Tr somatic change from an 8A homopolymeric tract to a
9A tract at 9821 was associated with UV-induced tumor formation,
we sought to explore whether the mtBALB haplotype would be
more resistant to apoptosis, a feature seen in many tumors. We exam-
ined UV-induced apoptosis in the cybrids by exposing the cultured
cells to UVA followed by measuring ﬂuorescent markers of apoptosis
and necrosis. Fig. 5B indicates that mtBALB cells were signiﬁcantly
less sensitive to UVA-induced apoptotic cell death than mtB6. There
was a signiﬁcant lower number of mtBALB cybrids positively stained
with Annexin V entering apoptosis. These results demonstrated that
the phenotype of resistance to apoptosis that is seen in some UV-
induced tumors can be conferred to cybrid cells by the transfer of
mtDNA containing mt-Tr 9821insA.Fig. 5.mtBALB cybrids resist UVA-induced apoptosis compared to mtB6 cybrids. Cells were e
Annexin V-positive cells are shown as apoptotic and 7-AAD-positive cells are shown as necr
Asterisk indicates statistical difference between mtB6 and mtBALB cybrid cells (*P valueb .03.6. Migration and invasion capabilities of mtBALB cybrids are enhanced
compared to mtB6 cybrids
Another behavior of cells that is associated with tumors is their
ability to migrate and invade [18–20]. We sought to examine whether
the mtBALB haplotype would be associated with higher levels of cell
migration and invasiveness compared to mtB6 haplotype cells. We
conducted transwell migration and invasion assays to determine the
migratory and invasive potential of the various cybrids. mtBALB
cybrids demonstrated 3-fold higher migration through uncoated in-
serts (Fig. 6A, B) than mtB6 cybrids. In order to eliminate the possibil-
ity that higher numbers of the mtBALB cybrids might be caused by an
initial migration followed by an increase in proliferation of the cells,
we also executed parallel transwell migration experiments with the
addition of 10 μg/ml Mitomycin C (Mito C) (Fig. 6C, D) to mitotically
inactivate the cells. These experiments excluded enhanced mtBALB
proliferation as an explanation for the increased numbers of cells on
the distal aspect of the transwell insert as all of the cybrid cells dis-
played similar motility characteristics after treatment with Mito C, al-
though they were rendered incapable of further cell division (Fig. 2B).
As indicated by Fig. 6E, F mtBALB cells also showed signiﬁcantly in-
creased (2.5-fold) invasion ability through matrigel coated inserts in
comparison to mtB6 cybrids. This behavior of increased invasiveness
is a feature that is associated with a phenotype of malignant cells
[18–20].
3.7. Antioxidants signiﬁcantly decreased migration and invasion
capabilities of mtBALB cybrids
As was seen in the experiments on proliferation, the antioxidant
compounds vit E and NAC were also able to diminish the migratory
capacity of the cybrid cells in transwell assays (Fig. 6G, H). The addi-
tion of NAC resulted in the signiﬁcant reduction in the migration of
the mtBALB cybrids which caused them to migrate at a level that
was similar to the mtB6 cybrid cells. The addition of vit E to the trans-
well assays resulted in a signiﬁcant decrease in migration for bothither (A) mock treated (0 J UVA) or (B) irradiated with 15 J of UVA to induce cell death.
otic. Values represent the mean±SEM of three independent experiments of ﬁve clones.
5).
Fig. 6.Migration and invasion capabilities of mtBALB cybrids are enhanced compared to mtB6 and are modulated by ROS levels. Migration transwell assays were performed using
uncoated inserts and invasion assays were conducted on inserts coated with matrigel. The bar graph shows the number of cybrid cells migrated through uncoated inserts in the
absence (A) or presence (C) of Mito C. Representative microscopic pictures of stained cells that migrated through the pores of the uncoated inserts in the absence (B) or presence
(D) of Mito C. (E) The bar graph shows the number of invading cells through the matrigel-coated inserts. (F) Representative microscopic pictures of cells that invaded through the
pores of the matrigel-coated inserts. The number of cells migrated through uncoated inserts in the presence of vit E (G) or NAC (H). Asterisk indicates statistical difference in mi-
gration or invasion between mtB6 and mtBALB cybrid cells (*P valueb .005). Data are mean±SEM of three independent experiments of three clones.
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levels of migration that are similar to untreated mtB6 cybrids. The
similar reduction of migration seen in mtBALB cells treated with
NAC or vit E are suggestive of an effect potentially mediated through
hydroxyl radical (·OH) that is scavenged by both compounds [21].
4. Discussion
The biochemical differences between the cybrids suggest that ener-
geticmetabolismmay be directly linked to neoplastic behavior. This no-
tion of glycolytic metabolism as a key component of cellular
transformation was proposed more than 50 years ago [22]. More re-
cently, the discovery of mutations in complex II subunits causing famil-
ial tumors syndromes involving paraganglioma tumors [23], and
mutations in fumarate hydratase causing familial leiomyomas and
renal cell carcinomas [24–27] have implicated enzymes involved in mi-
tochondrial energy production as dual-role proteins, involved in both
metabolism and tumor suppression. mtDNA alterations such as seen
in the mtBALB haplotype that result in diminished levels of complex I
protein, lower levels of baseline oxygen consumption, lower cellular
ATP production and enhanced CII substrate sensitivity [4] may provide
a biochemical environment that promotes cellular hyperproliferationas was seen in the mtBALB cybrids. Additionally, increased levels of en-
dogenous ROSmay provide a prolongedmitogenic cell signal, and is ca-
pable of direct nuclear DNA and mtDNA mutagenesis. Increased levels
of ROS may also set up a cycle of oxidative damage to mtDNA which
will further perturb OXPHOS activity and inhibit electron ﬂow through
the respiratory chain, with resulting further increases in ROS liberation.
Our results conﬁrm the data ofMoreno-Loshuertos et al. who gener-
ated similar transmitochondrial cybrids and showed decreased prolifer-
ation of mtBALB cybrids by NAC as well as diminished proliferation of
mtB6 L929 cybrid cells when exposed to NAC [5]. We did observe cer-
tain differences in the behavior of our cybrid cell lines in proliferation
rate and the selectivity of the antiproliferative effects of speciﬁc antiox-
idants on mtBALB cybrids. Nuclear background as well as observed dif-
ferences in the levels of measured ROS in their cybrids may explain the
differences between their experimental ﬁndings and these presented in
this paper. The differences in observed responses to antioxidants by the
cell lines likely reﬂect the speciﬁc differences in oxygen scavenging ac-
tivity of different compounds for the speciﬁc radicals generated by the
various mtDNA haplotypes.
For the ﬁrst time, we demonstrate that mtDNA changes such as seen
in mtBALB haplotype can produce signiﬁcant alterations in migration
and invasion capabilities of cybrid cells. We have also shown that
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have profound inﬂuence on migration abilities since antioxidants NAC
and vit E were able to diminish the migratory capacity of the mtBALB
cells and caused them to migrate at a level that was similar to the
mtB6 cells. Obtained data support a role of ROS as speciﬁc second mes-
sengers in signaling cascades involved not only in cell proliferation and
differentiation but in migration as well [11–15,17].
Changes in mtDNA associated with somatic mutation and subse-
quent allelic segregation may have broad consequences including dif-
ferences in cellular metabolism and more complex phenotypes such
as cell growth, inducible resistance to cell death stimuli and prolifer-
ation, migration and invasion. These results strongly support a poten-
tial contribution of mtDNA changes in cancer progression. The
profound differences in cellular physiology displayed by the cybrids
may explain some of the varying predispositions to developing tissue
speciﬁc malignancies in some mouse strains [28]. Of the three nucle-
otide changes between the two mtDNA types, the 9821insA in mt-Tr
locus together with 9348G to A base change are likely to be the
most important contributors to these diverse phenotypes since the
9461T to C change is a neutral polymorphism coding the same
amino acid (Methionine) in both haplotypes. Given the highly pleo-
morphic consequences of inherited tRNA mutations in human mito-
chondrial disease, it is not surprising that these minimal changes in
the mtDNA may be linked to such diverse cellular and organismal
changes such as learning, hearing, metabolism, and neoplasia. The
insA nucleotide change occurs in dihydrouridine-loop region of the
tRNA molecule and alters the length of the loop between the two
D-stem segments. Alteration in this region can produce profound
and highly pleomorphic phenotypes as evidenced by the A3243G
mutation in tRNALeu [29,30] occurring in mitochondrial encephalo-
myopathy, lactic acidosis and stroke-like episodes (MELAS) [31,32],
maternally inherited diabetes with or without deafness (DMDF)
[33–35] and mitochondrial myopathy (MM). The wide spectrum of
clinical phenotypes is likely caused by changes in heteroplasmy levels
in different tissues as well as differing tissue-speciﬁc energetic re-
quirements. In the case of neoplasia associated with somatic mtDNA
mutation, a mechanism of “loss of mtDNA heteroplasmy” coupled
with transforming nuclear DNA mutations may allow for the expres-
sion of a tumor promoting biochemical phenotype such as that seen
in the mitochondrial mtBALB cybrids.
While the role of mtDNA mutations in the development of kerati-
nocyte neoplasia is not fully understood, the investigation of the role
of mtDNA changes in the development of skin tumors might give us
the necessary clues to better understand the complex and multistep
process of skin carcinogenesis and detection of mtDNA mutations
can potentially be used as an early screening tool for squamous cell
carcinoma. Moreover, modulation of ROS mediated cell signaling
would be a prime target based on our observations. In conclusion, fur-
ther understanding of the role of mtDNA mutations in skin cancer as
well as other malignancies may help to identify new molecular tar-
gets for cancer therapies. An interesting corollary to somatic mtDNA
mutations supporting the phenotypes seen in tumor cells is that alter-
ing mitochondrial function in skin may have distinct and desired ad-
vantages in certain disease status. In chronic wounds, when increased
cellular motility is desired or in atrophic conditions of the skin, when
increased cellular proliferation would correct the pathological pro-
cess, altered mitochondrial function may be advantageous. Topical
medications modulating the downstream effects of ROS signaling
would be a natural therapeutic target in these diseases status.
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